Skip to content
healthcare.dev

Rasagiline

NDC 0093-3061, Rasagiline, tablet, from Teva Pharmaceuticals USA, Inc..

Product NDC
0093-3061
Status
Listed
Labeler
Teva Pharmaceuticals USA, Inc.
Dosage form
TABLET
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
NDA AUTHORIZED GENERIC
Application
NDA021641
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/0093-3061 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • RASAGILINE MESYLATE1 mg/1

Pharmacologic classes

Monoamine Oxidase Inhibitor [EPC]; Monoamine Oxidase Inhibitors [MoA]

Package NDCNDC-11Package
0093-3061-560009330615630 TABLET in 1 BOTTLE (0093-3061-56)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/e802c83c-e581-4a11-b83d-1df47120078d
  • NADAC price for package 00093306156

    GET /v1/drugs/nadac/00093306156

Use it

Look up 0093-3061 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/0093-3061 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 0093-3061. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.